DBZ blocks Lps-induced monocyte activation and foam cell formation via inhibiting nuclear factor-κB

Cellular Physiology and Biochemistry

Volumn 28, Issue 4, 2011, Pages 649-662

  Xie, Xinni ^a   Wang, Shixiang ^a   Xiao, Lei ^a   Zhang, Jun ^a   Wang, Jing ^a   Liu, Jin ^a   Shen, Xuji ^a   He, Dacheng ^a   Zheng, Xiaohui ^a,b   Zhai, Yonggong ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

Author keywords

Foam cell; Inflammation; Monocyte activation; NF B

Indexed keywords

DANSHENSU BINGPIAN ZHI; HERBACEOUS AGENT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LUCIFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CONTROLLED STUDY; DEGRADATION; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; FOAM; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 83755195393     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335760     Document Type: Article

References (55)

1. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868-874. (Pubitemid 36019640)
2. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135-1143. (Pubitemid 34212626)
3. Plenz G, Robenek H: Monocytes/ macrophages in atherosclerosis. Eur Cytokine Netw 1998;9:701-703.
4. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-439. (Pubitemid 2068912)
5. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK: Dental infection and the risk of new coronary events: Prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995;20:588-592.
6. Jousilahti P, Salomaa V, Rasi V, Vahtera E: Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk. Atherosclerosis 1999;142:403-407. (Pubitemid 29059499)
7. Young JL, Libby P, Schonbeck U: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002;88:554-567. (Pubitemid 35173995)
8. Cuaz-Perolin C, Billiet L, Bauge E, Copin C, Scott-Algara D, Genze F, Buchele B, Syrovets T, Simmet T, Rouis M: Antiinflammatory and antiatherogenic effects of the nf-kappab inhibitor acetyl-11-keto-beta-boswellic acid in lpschallenged apoe-/-mice. Arterioscler Thromb Vasc Biol 2008;28:272-277. (Pubitemid 351161199)
9. Lopez-Franco O, Hernandez-Vargas P, Ortiz-Munoz G, Sanjuan G, Suzuki Y, Ortega L, Blanco J, Egido J, Gomez-Guerrero C: Parthenolide modulates the nf-kappab-mediated inflammatory responses in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:1864-1870. (Pubitemid 44305342)
10. Tak PP, Firestein GS: Nf-kappab: A key role in inflammatory diseases. J Clin Invest 2001;107:7-11. (Pubitemid 32047405)
11. de Winther MP, Kanters E, Kraal G, Hofker MH: Nuclear factor kappab signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005;25:904-914. (Pubitemid 40627833)
12. Karin M: The regulation of ap-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486.
13. Whitmarsh AJ, Davis RJ: Transcription factor ap-1 regulation by mitogenactivated protein kinase signal transduction pathways. J Mol Med 1996;74:589-607. (Pubitemid 26343761)
14. Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR: Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of nf-kappa b and ap-1. Eur J Immunol 1997;27:1091-1097. (Pubitemid 27197210)
15. Sweet MJ, Hume DA: Endotoxin signal transduction in macrophages. J Leukoc Biol 1996;60:8-26. (Pubitemid 26248877)
16. Adcock IM: Transcription factors as activators of gene transcription: Ap-1 and nf-kappa b. Monaldi Arch Chest Dis 1997;52:178-186. (Pubitemid 27308290)
17. Kalayoglu MV, Byrne GI: A chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998;66:5067-5072. (Pubitemid 29044592)
18. Crowe SM, Westhorpe CL, Mukhamedova N, Jaworowski A, Sviridov D, Bukrinsky M: The macrophage: The intersection between hiv infection and atherosclerosis. J Leukoc Biol 2010;87:589-598.
19. Chen S, Sorrentino R, Shimada K, Bulut Y, Doherty TM, Crother TR, Arditi M: Chlamydia pneumoniae-induced foam cell formation requires myd88-dependent and -independent signaling and is reciprocally modulated by liver x receptor activation. J Immunol 2008;181:7186-7193.
20. Funk JL, Feingold KR, Moser AH, Grunfeld C: Lipopolysaccharide stimulation of raw 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis 1993;98:67-82. (Pubitemid 23010425)
21. Memon RA, Staprans I, Noor M, Holleran WM, Uchida Y, Moser AH, Feingold KR, Grunfeld C: Infection and inflammation induce ldl oxidation in vivo. Arterioscler Thromb Vasc Biol 2000;20:1536-1542. (Pubitemid 30353885)
22. Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, Witztum JL, Bae YS, Miller YI: Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009;104:1355-1363.
23. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR: Endotoxin down-regulates abcg5 and abcg8 in mouse liver and abca1 and abcg1 in j774 murine macrophages: Differential role of lxr. J Lipid Res 2003;44:1728-1736. (Pubitemid 37185884)
24. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR: Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol 2005;25:1220-1224. (Pubitemid 40776612)
25. Fu Y, Luo N, Lopes-Virella MF: Oxidized ldl induces the expression of albp/ap2 mrna and protein in human thp-1 macrophages. J Lipid Res 2000;41:2017-2023. (Pubitemid 32038997)
26. Feingold KR, Kazemi MR, Magra AL, McDonald CM, Chui LG, Shigenaga JK, Patzek SM, Chan ZW, Londos C, Grunfeld C: Adrp/adfp and mal1 expression are increased in macrophages treated with tlr agonists. Atherosclerosis 2010;209:81-88.
27. Gu JQ, Ikuyama S, Wei P, Fan B, Oyama J, Inoguchi T, Nishimura J: Pycnogenol, an extract from french maritime pine, suppresses toll-like receptor 4-mediated expression of adipose differentiationrelated protein in macrophages. Am J Physiol Endocrinol Metab 2008;295:E1390-1400.
28. Wang X, Reape TJ, Li X, Rayner K, Webb CL, Burnand KG, Lysko PG: Induced expression of adipophilin mrna in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions. FEBS Lett 1999;462:145-150.
29. Fu Y, Luo L, Luo N, Garvey WT: Lipid metabolism mediated by adipocyte lipid binding protein (albp/ap2) gene expression in human thp-1 macrophages. Atherosclerosis 2006;188:102-111. (Pubitemid 44142544)
30. Gao J, Serrero G: Adipose differentiation related protein (adrp) expressed in transfected cos-7 cells selectively stimulates long chain fatty acid uptake. J Biol Chem 1999;274:16825-16830.
31. Larigauderie G, Furman C, Jaye M, Lasselin C, Copin C, Fruchart JC, Castro G, Rouis M: Adipophilin enhances lipid accumulation and prevents lipid efflux from thp-1 macrophages: Potential role in atherogenesis. Arterioscler Thromb Vasc Biol 2004;24:504-510. (Pubitemid 38326145)
32. Imamura M, Inoguchi T, Ikuyama S, Taniguchi S, Kobayashi K, Nakashima N, Nawata H: Adrp stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am J Physiol Endocrinol Metab 2002;283:E775-783.
33. Fu Y, Luo N, Lopes-Virella MF, Garvey WT: The adipocyte lipid binding protein (albp/ap2) gene facilitates foam cell formation in human thp-1 macrophages. Atherosclerosis 2002;165:259-269. (Pubitemid 35333352)
34. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF: Lack of macrophage fatty-acidbinding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001;7:699-705. (Pubitemid 32588026)
35. Paul A, Chang BH, Li L, Yechoor VK, Chan L: Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis. Circ Res 2008;102:1492-1501.
36. Cheng TO: Cardiovascular effects of Danshen. Int J Cardiol 2007;121:9-22. (Pubitemid 47287779)
37. Zhou L, Zuo Z, Chow MS: Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005;45:1345-1359. (Pubitemid 41643896)
38. Chan K, Chui SH, Wong DY, Ha WY, Chan CL, Wong RN: Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction Life Sci 2004;75:3157-317
39. Ding M, Yuan YJ: Study on the mechanisms of an extract of Salvia miltiorrhiza on the regulation of permeability of endothelial cells exposed to tumour necrosis factor-alpha. J Pharm Pharmacol 2007;59:1027-1033. (Pubitemid 47051085)
40. Chen LN, Zhu XX: Advances in study of the pharmacological effects of danshen on hemorheology. Zhongguo Zhong Yao Za Zhi 2005;30:630-633, 640.
41. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H, Kimura I: Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 2008;117:280-295.
42. Wu L, Qiao H, Li Y, Li L: Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats. Phytomedicine 2007;14:652-658. (Pubitemid 47419302)
43. Cai Z, Hou S, Li Y, Zhao B, Yang Z, Xu S, Pu J: Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target 2008;16:178-184. (Pubitemid 351266554)
44. Chen TF, Lin SG, Chen LX, Jiang GF, Liang ZY, Yang M, Qian YZ, Xie YA: Enhancement of absorption of tetramethylpyrazine by synthetic borneol. Zhongguo Yao Li Xue Bao 1990;11:42-44. (Pubitemid 20060948)
45. Yang H, Xun Y, Li Z, Hang T, Zhang X, Cui H: Influence of borneol on in vitro corneal permeability and on in vivo and in vitro corneal toxicity. J Int Med Res 2009;37:791-802.
46. Zhai Y, Wada T, Zhang B, Khadem S, Ren S, Kuruba R, Li S, Xie W: A functional cross-talk between liver x receptor-alpha and constitutive androstane receptor links lipogenesis and xenobiotic responses. Mol Pharmacol 2010;78:666-674.
47. Ding GJ, Fischer PA, Boltz RC, Schmidt JA, Colaianne JJ, Gough A, Rubin RA, Miller DK: Characterization and quantitation of nf-kappab nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem 1998;273:28897-28905.
48. Xia M, Hou M, Zhu H, Ma J, Tang Z, Wang Q, Li Y, Chi D, Yu X, Zhao T, Han P, Xia X, Ling W: Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor-liver X receptor ABCA1 pathway. J Biol Chem 2005;280:36792-36801. (Pubitemid 41587759)
49. Wang WJ, Wu XZ, Yao Z, Li HQ: The influence of Emodin and Danshensu on monocyte's secretion of inflammatory cytokines. Chinese J Immunol 1995;06:370-372.
50. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-281. (Pubitemid 128373654)
51. Wiesner P, Choi SH, Almazan F, Benner C, Huang W, Diehl CJ, Gonen A, Butler S, Witztum JL, Glass CK, Miller YI: Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa b and activator protein-1: Possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res 2010;107:56-65.
52. Zhang G, Ghosh S: Toll-like receptormediated nf-kappab activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001;107:13-19. (Pubitemid 32047406)
53. Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, Kim SH, Kim JG, Kim CH: Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism. Faseb J 2004;18:1670-1681. (Pubitemid 39463706)
54. Lopes-Virella MF, Klein RL, Stevenson HC: Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products. Arteriosclerosis 1987;7:176-184. (Pubitemid 17061139)
55. Hui X, Li H, Zhou Z, Lam KS, Xiao Y, Wu D, Ding K, Wang Y, Vanhoutte PM, Xu A:Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-jun nh2-terminal kinases and activator protein-1. J Biol Chem 2010;285:10273-10280.